Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi, Jackson S. Turner, James Brett Case, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 4, pp. 915-922
Open Access | Times Cited: 209

Showing 26-50 of 209 citing articles:

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2143-2158.e15
Open Access | Times Cited: 193
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 522-528.e2
Open Access | Times Cited: 192
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
James Brett Case, Paul W. Rothlauf, Rita E. Chen, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 3, pp. 465-474.e4
Open Access | Times Cited: 180
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
Michael Heming, Xiaolin Li, Saskia Räuber, et al.
Immunity (2020) Vol. 54, Iss. 1, pp. 164-175.e6
Open Access | Times Cited: 156
Antibody structure prediction using interpretable deep learning
Jeffrey A. Ruffolo, Jeremias Sulam, Jeffrey J. Gray
Patterns (2021) Vol. 3, Iss. 2, pp. 100406-100406
Open Access | Times Cited: 156
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
S. Wesley Long, Randall J. Olsen, Paul A. Christensen, et al.
mBio (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 137
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 136
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Maritza Puray‐Chavez, Kyle M. LaPak, Travis P. Schrank, et al.
Cell Reports (2021) Vol. 36, Iss. 2, pp. 109364-109364
Open Access | Times Cited: 132
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109452-109452
Open Access | Times Cited: 119
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Andrew C. Hunt, James Brett Case, Young‐Jun Park, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 97
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
Pei Li, Yajie Liu, Julia N. Faraone, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 26
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing Antibodies
Abigail Vanderheiden, Venkata Viswanadh Edara, Katharine Floyd, et al.
Current Protocols in Immunology (2020) Vol. 131, Iss. 1
Open Access | Times Cited: 132
COVID-19 antibodies on trial
Laura DeFrancesco
Nature Biotechnology (2020) Vol. 38, Iss. 11, pp. 1242-1252
Open Access | Times Cited: 119
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
Jorge Carrillo, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 187-191
Open Access | Times Cited: 114
Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 104
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
Cong Zeng, John P. Evans, Rebecca M. Pearson, et al.
JCI Insight (2020) Vol. 5, Iss. 22
Open Access | Times Cited: 100
Single-cell immunology of SARS-CoV-2 infection
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 1, pp. 30-41
Open Access | Times Cited: 100
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar, Anmol Chandele, Amit Sharma
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009885-e1009885
Open Access | Times Cited: 97
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A. VanBlargan, Lucas J. Adams, Zhuoming Liu, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2399-2416.e6
Open Access | Times Cited: 94
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Emelissa J. Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 4, pp. 115294-115294
Open Access | Times Cited: 92

Scroll to top